Impact Of Preoperative Spherical Aberration On Refractive Outcomes With An Extended Depth-Of-Focus (Edof) Intraocular Lens (Iol)
Published 2026 - 44th Congress of the ESCRS
Reference: PP12.02 | Type: Free paper | DOI: 10.82333/4z88-cw83
Authors: Dr Miguel Ángel Castro-Monreal 1 , Dr Rebeca Paquentín-Jiménez 1 , Dr Alejandra Beltrán-Castillo* 1 , Dr Roberto González-Salinas 1
1Ophthalmology,Association for the Prevention of Blindness in Mexico (APEC),Mexico City,Mexico
Purpose
To determine the correlation between preoperative corneal spherical aberration (SA) and visual performance at different distances after implantation of the AcrySof IQ Vivity® extended depth-of-focus (EDOF) intraocular lens (IOL).
Setting
Association for the Prevention of Blindness in Mexico (Asociación Para Evitar la Ceguera en México I.A.P; APEC) Mexico City, Mexico (September 2023-December 2024).
Methods
Prospective study including 121 eyes undergoing phacoemulsification with implantation of the Vivity® EDOF IOL (Alcon). Pre- and postoperative corneal SA was evaluated using aberrometry (OPD-Scan III, Nidek) and corneal tomography (Pentacam, Oculus). Visual acuity (VA) was assessed with defocus curves for distance, intermediate and near vision. Statistical analyses included Wilcoxon tests, Student's t-test, Spearman correlation, and linear regression.
Results
No significant differences were found between pre- and postoperative corneal SA (p=0,41). In the overall analysis, SA did not correlate with VA at any distance. Nevertheless, subgroup analysis showed that in patients with SA > 0,27 µm (34%), higher SA was significantly associated with worse intermediate visual performance (r=0,45; p<0,05), explaining 20,2% of its variability. No significant association was found between pupil size and VA at different distances.
Conclusions
Preoperative corneal SA influences intermediate vision quality with the Vivity® IOL, particularly in eyes with values > 0,27 µm. Preoperative SA assessment is a useful variable to select candidates and predict outcomes, thereby optimizing patient satisfaction with this EDOF technology.